94 related articles for article (PubMed ID: 464443)
21. Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Bailey CC; Marsden HB; Jones PH
Cancer; 1978 Jul; 42(1):74-6. PubMed ID: 667809
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Ryan BR; Walters TR
Cancer; 1981 Aug; 48(4):909-11. PubMed ID: 7272934
[TBL] [Abstract][Full Text] [Related]
23. 25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood.
Lohani S; O'Driscoll BR; Woodcock AA
Chest; 2004 Sep; 126(3):1007. PubMed ID: 15364795
[No Abstract] [Full Text] [Related]
24. Irreversible pulmonary toxicity after single course of BCNU.
Lieberman A; Ruoff M; Estey E; Seidman I; Lieberman I; Wise A
Am J Med Sci; 1980; 279(1):53-6. PubMed ID: 7369249
[TBL] [Abstract][Full Text] [Related]
25. The pulmonary toxicity of antineoplastic agents.
Ginsberg SJ; Comis RL
Semin Oncol; 1982 Mar; 9(1):34-51. PubMed ID: 6176027
[No Abstract] [Full Text] [Related]
26. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
Helal GK; Helal OK
Arch Toxicol; 2009 Jan; 83(1):87-94. PubMed ID: 18528683
[TBL] [Abstract][Full Text] [Related]
27. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
O'Driscoll BR; Hasleton PS; Taylor PM; Poulter LW; Gattameneni HR; Woodcock AA
N Engl J Med; 1990 Aug; 323(6):378-82. PubMed ID: 2370889
[TBL] [Abstract][Full Text] [Related]
28. Carmustine and the lungs .
Schmitz N; Diehl V
Lancet; 1997 Jun; 349(9067):1712-3. PubMed ID: 9193378
[No Abstract] [Full Text] [Related]
29. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
Selker RG; Jacobs SA; Moore PB; Wald M; Fisher ER; Cohen M; Bellot P
Neurosurgery; 1980 Dec; 7(6):560-5. PubMed ID: 7207751
[TBL] [Abstract][Full Text] [Related]
30. [Nitrosourea-induced lung diseases].
Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
[TBL] [Abstract][Full Text] [Related]
31. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
[TBL] [Abstract][Full Text] [Related]
32. Fatal pneumothorax in "BCNU lung".
Wilson KS; Brigden ML; Alexander S; Worth A
Med Pediatr Oncol; 1982; 10(2):195-9. PubMed ID: 7070355
[TBL] [Abstract][Full Text] [Related]
33. Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.
Patten GA; Billi JE; Rotman HH
JAMA; 1980 Aug; 244(7):687-8. PubMed ID: 7392168
[No Abstract] [Full Text] [Related]
34. [Toxic effects of cytostatic agents on the lung in monochemotherapy and polychemotherapy].
Renovanz HD
Wien Med Wochenschr; 1983 Apr; 133(7):159-67. PubMed ID: 6868616
[No Abstract] [Full Text] [Related]
35. [Diagnosis and prophylaxis of lung changes induced by cytostatics ("cytostatic-pneumopathy")].
Stobbe H; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):707-14. PubMed ID: 6172338
[No Abstract] [Full Text] [Related]
36. Carmustine toxicity presenting as a lobar infiltrate.
Patterson DL; Wiemann MC; Lee TH; Byron WA
Chest; 1993 Jul; 104(1):315-7. PubMed ID: 8325102
[TBL] [Abstract][Full Text] [Related]
37. The nitrosoureas and pulmonary toxicity.
Weiss RB; Poster DS; Penta JS
Cancer Treat Rev; 1981 Jun; 8(2):111-25. PubMed ID: 6454489
[No Abstract] [Full Text] [Related]
38. Chemotherapy-induced fatal pulmonary fibrosis.
Somló P; Révész T
Neoplasma; 1984; 31(6):739-44. PubMed ID: 6521801
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
Richter JE; Hastedt R; Dalton JF; Marshall D; Raymond LW
Cancer; 1979 May; 43(5):1607-12. PubMed ID: 445356
[TBL] [Abstract][Full Text] [Related]
40. Nitrosourea-associated pulmonary fibrosis.
Hundley RF; Lukens JN
Cancer Treat Rep; 1979; 63(11-12):2128-30. PubMed ID: 526951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
